Allarity Therapeutics Inc (NASDAQ:ALLR)’s traded shares stood at 0.85 million during the last session, with the company’s beta value hitting 0.31.The ALLR share’s 52-week high remains $342.00, putting it -31566.67% down since that peak but still an impressive 16.67% since price per share fell to its 52-week low of $0.90. The company has a valuation of $4.79M, with an average of 0.76 million shares in intraday trading volume over the past 10 days and average of 462.94K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Allarity Therapeutics Inc (ALLR), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ALLR a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -8.1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
The 5-day price performance for the stock is 4.85%, and -12.90% over 30 days. With these gigs, the year-to-date price performance is -99.67%. Short interest in Allarity Therapeutics Inc (NASDAQ:ALLR) saw shorts transact 0.18 million shares and set a 0.3 days time to cover.
Allarity Therapeutics Inc (ALLR) estimates and forecasts
Looking at statistics comparing Allarity Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Allarity Therapeutics Inc (ALLR) shares are -83.09% down over the last 6 months, with its year-to-date growth rate higher than industry average at 98.73% against 16.60%.
ALLR Dividends
Allarity Therapeutics Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Allarity Therapeutics Inc (ALLR) shares. Going by data provided on Oct 31, 2024 , Fidelity Extended Market Index Fund holds roughly 7.19 shares. This is just over 0.16% of the total shares, with a market valuation of $7767.0. Data from the same date shows that the other fund manager holds a little less at 2.6, or 0.06% of the shares, all valued at about 2809.0.
